Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection of infectious prion protein by seeded conversion of recombinant prion protein

a technology of prion protein and seeded conversion, which is applied in the field of detection of infectious proteins or prions, can solve the problems of complicated detection of rprp-ressup, and achieve the effects of limiting the transmission of prion diseases, and reducing the risk of infection

Active Publication Date: 2009-02-19
UNITED STATES OF AMERICA
View PDF10 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a new and very sensitive method for detecting prion protein using a recombinant protein called rPrP-sen. This method is faster and more sensitive than existing methods and can detect extremely low levels of prion protein. The method involves mixing a sample with rPrP-sen and performing an amplification reaction using various steps to form and amplify specific forms of rPrP-res. The amplified rPrP-res is then detected as an indicator of any prion protein in the sample. The method can be carried out in a single round or in a serial amplification reaction. The patent also describes a new method called QUIC that uses shaking instead of sonication to transmit the energy needed for dissociating aggregates. This method is easier to repeat and retains high sensitivity. Overall, the patent provides a faster and more reliable method for detecting prion protein which can help in the diagnosis and prevention of prion diseases.

Problems solved by technology

In particular embodiments, the amplification reaction is carried out under conditions that inhibit production of spontaneously aggregated rPrP-res (rPrP-res(spon)) that is independent of the presence of PrP-res in the sample, because that by-product has surprisingly been found to interfere with the desired aggregation reaction of rPrP with PrP-res and can complicate the detection of rPrP-res(Sc).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection of infectious prion protein by seeded conversion of recombinant prion protein
  • Detection of infectious prion protein by seeded conversion of recombinant prion protein
  • Detection of infectious prion protein by seeded conversion of recombinant prion protein

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods

[0220]This example describes materials and methods used to carry out Examples 2-8. Although particular methods are described, it is understood that other methods can be used.

Recombinant prion protein expression and purification

[0221]DNA sequences coding for hamster (GENBANK® Accession No. M14054) and mouse (GENBANK® Accession No. BC006703) prion protein residues 23-230 or 90-230 were amplified by standard PCR, ligated into the Kanamycin selective pET41 vector (EMD Biosciences) as NdeI / HindIII inserts, and their sequences were verified. After transforming the plasmids into E. coli Rosetta cells (EMD Biosciences), the rPrP-sen was expressed using the Overnight Express Autoinduction system according to the instructions from the manufacturer (EMD Biosciences). A typical mass of wet cell paste was 8-9 grams per Liter of Luria-Bertani media. Cell pellets were lysed with BugBuster™ and Lysonase™ (EMD Biosciences). Approximately 25 mL of BugBuster™ with 50 μL of lysonas...

example 2

Spontaneous Conversion of rPrP-sen

[0235]This Example describes the identification of an exemplary set of reaction conditions that allow clear discrimination between PrPSc-seeded and unseeded reaction products. Although particular reaction conditions are specified, one will recognize that other reaction conditions can be used.

[0236]Development of a PMCA-like reaction for PrPSc amplification using rPrP-sen as a substrate requires conditions that allow for clear discrimination between PrPSc-seeded and unseeded reaction products. Initial trials revealed that in 0.1% SDS with periodic sonications, bacterially expressed recombinant mouse PrP-sen (rMoPrP-sen; FIG. 5) and hamster PrP-sen (rHaPrP-sen) converted spontaneously to thioflavin T-positive, proteinase K (PK)-resistant forms designated rMoPrP-res(spon) and rHaPrP-res(spon), respectively. The fragments generated by PK-digestion of rMoPrP-res(spon) and rHaPrP-res(spon) were 10-12 kDa, that is, much smaller than the ˜17-19 kDa fragment...

example 3

Seeding of rPrP-sen conversion by PrPSc

[0237]This example demonstrates that scrapie PrPSc can seed the conversion of rPrP-sen to rPrP-res.

[0238]Scrapie PrPSc purified from hamster brains (HaPrPSc; Raymond & Chabry in Techniques in Prion Research (eds. Lehmann & Grassi) 16-26 (Birkhauser Verlag, Basel, 2004)) was used to seed the conversion of rHaPrP-sen. PK-resistant fragments seeded by PrPSc (rHaPrP-res(Sc), where (Sc) refers to seeding by PrPSc) were generated with seed-to-substrate ratios of 1:100 (400 ng HaPrPSc) and 1:1,000 (40 ng HaPrPSc) in both the unsonicated and sonicated reactions, but, when sonicated were much more abundant and less dependent on the amount of seed (FIG. 1A). When analyzed by immunoblotting using an anti-PrP antibody R20 directed toward C-terminal residues 219-232, rHaPrP-res(Sc) consisted of 4 PK-resistant fragments (11, 12, 13 and 17 kDa). In contrast, and as expected, the unseeded reactions gave either no PK-resistant bands (FIG. 1A) or, more rarely, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present disclosure relates to methods and compositions for the detection of infectious proteins or prions in samples, including the diagnosis of prion related diseases. One embodiment is an ultrasensitive method for detecting PrP-res (PrPSc) that allows the use of recombinant PrP-sen (rPrP-sen) as a substrate for seeded polymerization. A sample is mixed with purified rPrP-sen to make a reaction mix which is incubated to permit aggregation of the rPrP-sen with the PrP-res that may be present in the sample. Any aggregates are intermittently disaggregated by agitation (for example by sonication) and the reaction allowed to proceed to amplify target substrate. Any rPrP-res(Sc) in the reaction mix is detected to indicate the presence of PrP-res in the original sample. This assay, which is called rPrP-PMCA, is surprisingly much faster than existing PMCA methods, yet it still retains sufficient sensitivity to detect extremely low levels of PrP-res. An alternative of rPrP-PMCA is the QUIC method in which shaking of the reaction mixture is substituted for sonication. The surprising speed and efficiency of the method permits the rapid identification and diagnosis of prion disease, which can limit the transmission of prion diseases, particularly through the food supply.

Description

PRIORITY[0001]Benefit is claimed of U.S. Provisional Application 60 / 961,364, filed Jul. 20, 2007 and U.S. Provisional Application 61 / 021,865, filed Jan. 17, 2008. The disclosures of both of those provisional patent applications are incorporated by reference in their entirety.FIELD OF THE DISCLOSURE[0002]The present disclosure relates to methods and compositions for the detection of infectious proteins or prions in samples, including the diagnosis of prion related diseases.BACKGROUND[0003]Prion diseases, which are also called transmissible spongiform encephalopathies (TSEs), include a group of fatal infectious neurodegenerative diseases that include Creutzfeldt-Jakob disease (CJD), kuru, Gerstmann-Straussler Scheinker syndrome (GSS), fatal familial insomnia (FFI) and sporadic fatal insomnia (sFI) in humans, and scrapie, bovine spongiform encephalopathy (BSE) and chronic wasting disease (CWD) in animals. These diseases are characterized by brain vacuolation, astrogliosis, neuronal apo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/48G01N33/00G01N33/566C12Q1/02
CPCG01N33/6896G01N2800/28G01N2800/2828
Inventor CAUGHEY, BYRON W.ATARASHI, RYUICHIROMOORE, ROGER A.PRIOLA, SUZETTE A.
Owner UNITED STATES OF AMERICA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com